$CWBC
Community West Bancshares Stock $cwbc

$cwbc Overview Financials Valuation SEC Filings Company Website

2021 Q3 Form 10-Q Financial Statement

#000112737121000141 Filed on November 03, 2021

Income Statement

Concept	2021 Q3	2020 Q3	2020 Q2
Revenue	$18.50M	$16.43M	$15.98M
YoY Change	12.57%	-2.93%	-4.74%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$2.390M	$1.410M	$1.410M
YoY Change	69.5%	2.92%	-18.97%
% of Gross Profit
Operating Expenses
YoY Change
Operating Profit
YoY Change
Interest Expense	$287.0K	$388.0K	$410.0K
YoY Change	-26.03%	-46.26%	-50.84%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income	$8.796M	$5.786M	$3.121M
YoY Change	52.02%	-28.95%	-63.16%
Income Tax	$2.275M	$1.442M	$820.0K
% Of Pretax Income	25.86%	24.92%	26.27%
Net Earnings	$6.521M	$4.344M	$2.301M
YoY Change	50.12%	-23.67%	-62.2%
Net Earnings / Revenue	35.25%	26.44%	14.4%
Basic Earnings Per Share	$0.54	$0.35	$0.18
Diluted Earnings Per Share	$0.54	$0.35	$0.18
COMMON SHARES
Basic Shares Outstanding	12.01M shares	12.47M shares	12.45M shares
Diluted Shares Outstanding	12.04M shares	12.50M shares	12.49M shares

Balance Sheet

Concept	2021 Q3	2020 Q3	2020 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents	$67.69M	$87.01M	$118.6M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment	$8.429M	$7.257M	$7.257M
YoY Change	16.15%	-7.01%	-6.26%
Goodwill	$53.78M		$53.78M
YoY Change			0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets	$2.348B	$1.951B	$1.914B
YoY Change	20.4%	23.13%	18.63%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$38.60M	$28.40M	$30.50M
YoY Change	35.92%	-8.39%	7.77%
Accrued Expenses		$6.200M	$5.900M
YoY Change		-8.82%	-13.24%
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$38.60M	$28.40M	$30.50M
YoY Change	35.92%	-8.39%	7.77%
LONG-TERM LIABILITIES
Long-Term Debt	$5.200M	$5.200M	$5.200M
YoY Change	0.0%	0.0%	0.0%
Other Long-Term Liabilities	$14.90M	$9.900M	$10.60M
YoY Change	50.51%	-2.94%	8.16%
Total Long-Term Liabilities	$5.200M	$5.200M	$5.200M
YoY Change	0.0%	0.0%	0.0%
TOTAL LIABILITIES
Total Short-Term Liabilities	$38.60M	$28.40M	$30.50M
Total Long-Term Liabilities	$5.200M	$5.200M	$5.200M
Total Liabilities	$2.102B	$1.715B	$1.685B
YoY Change	22.57%	26.93%	21.98%
SHAREHOLDERS EQUITY
Retained Earnings	$168.0M	$145.0M	$142.1M
YoY Change	15.82%	9.11%	10.37%
Common Stock	$68.27M	$79.27M	$79.06M
YoY Change	-13.88%	-16.13%	-19.5%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$246.5M	$235.8M	$228.6M
YoY Change
Total Liabilities & Shareholders Equity	$2.348B	$1.951B	$1.914B
YoY Change	20.4%	23.13%	18.63%

Cashflow Statement

Concept	2021 Q3	2020 Q3	2020 Q2
OPERATING ACTIVITIES
Net Income	$6.521M	$4.344M	$2.301M
YoY Change	50.12%	-23.67%	-62.2%
Depreciation, Depletion And Amortization	$2.390M	$1.410M	$1.410M
YoY Change	69.5%	2.92%	-18.97%
Cash From Operating Activities	$4.300M	$5.050M	-$4.160M
YoY Change	-14.85%	-28.27%	-249.64%
INVESTING ACTIVITIES
Capital Expenditures	-$190.0K	-$210.0K	-$70.00K
YoY Change	-9.52%	-51.16%	-58.82%
Acquisitions
YoY Change
Other Investing Activities	-$127.6M	-$66.77M	-$211.1M
YoY Change	91.03%	-352.25%	629.77%
Cash From Investing Activities	-$127.7M	-$66.98M	-$211.1M
YoY Change	90.71%	-357.22%	625.75%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	70.46M	30.38M	297.7M
YoY Change	131.93%	-178.6%	597.45%
NET CHANGE
Cash From Operating Activities	4.300M	5.050M	-4.160M
Cash From Investing Activities	-127.7M	-66.98M	-211.1M
Cash From Financing Activities	70.46M	30.38M	297.7M
Net Change In Cash	-52.98M	-31.55M	82.39M
YoY Change	67.92%	466.43%	403.3%
FREE CASH FLOW
Cash From Operating Activities	$4.300M	$5.050M	-$4.160M
Capital Expenditures	-$190.0K	-$210.0K	-$70.00K
Free Cash Flow	$4.490M	$5.260M	-$4.090M
YoY Change	-14.64%	-29.59%	-238.64%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Entity Central Index Key EntityCentralIndexKey	0001127371
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2021
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2021Q3	us-gaap	Loans And Leases Receivable Allowance LoansAndLeasesReceivableAllowance	10061000	USD
CY2020Q4	us-gaap	Loans And Leases Receivable Allowance LoansAndLeasesReceivableAllowance	12915000	USD
CY2021Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2020Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2021Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2020Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
	dei	Entity Registrant Name EntityRegistrantName	CENTRAL VALLEY COMMUNITY BANCORP
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	CA
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	77-0539125
CY2021Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2020Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2021Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	80000000	shares
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	80000000	shares
CY2021Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	11987904	shares
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	12509848	shares
CY2021Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	11987904	shares
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	12509848	shares
CY2021Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0
CY2020Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0
CY2021Q3	cvcy	Financing Receivable Modifications Subsequent Defaults During Period Number Of Contracts FinancingReceivableModificationsSubsequentDefaultsDuringPeriodNumberOfContracts	0	contract
CY2020Q3	cvcy	Financing Receivable Modifications Subsequent Defaults During Period Number Of Contracts FinancingReceivableModificationsSubsequentDefaultsDuringPeriodNumberOfContracts	0	contract
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2021	dei	Document Period End Date DocumentPeriodEndDate	2021-09-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	000-31977
	dei	Entity Address Address Line1 EntityAddressAddressLine1	7100 N. Financial Dr., Suite 101
	dei	Entity Address City Or Town EntityAddressCityOrTown	Fresno
	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	93720
	dei	City Area Code CityAreaCode	559
	dei	Local Phone Number LocalPhoneNumber	298-1775
	dei	Security12b Title Security12bTitle	Common Stock, no par value
	dei	Trading Symbol TradingSymbol	CVCY
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2021Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	11988004	shares
CY2021Q3	us-gaap	Cash And Due From Banks CashAndDueFromBanks	32634000	USD
CY2020Q4	us-gaap	Cash And Due From Banks CashAndDueFromBanks	34175000	USD
CY2021Q3	us-gaap	Interest Bearing Deposits In Banks InterestBearingDepositsInBanks	35059000	USD
CY2020Q4	us-gaap	Interest Bearing Deposits In Banks InterestBearingDepositsInBanks	36103000	USD
CY2021Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	67693000	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	70278000	USD
CY2021Q3	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	1060362000	USD
CY2020Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	710092000	USD
CY2021Q3	us-gaap	Available For Sale Securities Equity Securities AvailableForSaleSecuritiesEquitySecurities	7486000	USD
CY2020Q4	us-gaap	Available For Sale Securities Equity Securities AvailableForSaleSecuritiesEquitySecurities	7634000	USD
CY2021Q3	us-gaap	Loans And Leases Receivable Net Reported Amount LoansAndLeasesReceivableNetReportedAmount	1073436000	USD
CY2020Q4	us-gaap	Loans And Leases Receivable Net Reported Amount LoansAndLeasesReceivableNetReportedAmount	1089432000	USD
CY2021Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	8429000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	8228000	USD
CY2021Q3	us-gaap	Bank Owned Life Insurance BankOwnedLifeInsurance	39309000	USD
CY2020Q4	us-gaap	Bank Owned Life Insurance BankOwnedLifeInsurance	28713000	USD
CY2021Q3	us-gaap	Federal Home Loan Bank Stock FederalHomeLoanBankStock	5595000	USD
CY2020Q4	us-gaap	Federal Home Loan Bank Stock FederalHomeLoanBankStock	5595000	USD
CY2021Q3	us-gaap	Goodwill Goodwill	53777000	USD
CY2020Q4	us-gaap	Goodwill Goodwill	53777000	USD
CY2021Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	662000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1183000	USD
CY2021Q3	cvcy	Accrued Interest Receivable And Other Assets AccruedInterestReceivableAndOtherAssets	31628000	USD
CY2020Q4	cvcy	Accrued Interest Receivable And Other Assets AccruedInterestReceivableAndOtherAssets	29164000	USD
CY2021Q3	us-gaap	Assets Assets	2348377000	USD
CY2020Q4	us-gaap	Assets Assets	2004096000	USD
CY2021Q3	us-gaap	Noninterest Bearing Deposit Liabilities Domestic NoninterestBearingDepositLiabilitiesDomestic	934249000	USD
CY2020Q4	us-gaap	Noninterest Bearing Deposit Liabilities Domestic NoninterestBearingDepositLiabilitiesDomestic	824889000	USD
CY2021Q3	us-gaap	Interest Bearing Deposit Liabilities Domestic InterestBearingDepositLiabilitiesDomestic	1123843000	USD
CY2020Q4	us-gaap	Interest Bearing Deposit Liabilities Domestic InterestBearingDepositLiabilitiesDomestic	897821000	USD
CY2021Q3	us-gaap	Deposits Deposits	2058092000	USD
CY2020Q4	us-gaap	Deposits Deposits	1722710000	USD
CY2021Q3	us-gaap	Junior Subordinated Debenture Owed To Unconsolidated Subsidiary Trust JuniorSubordinatedDebentureOwedToUnconsolidatedSubsidiaryTrust	5155000	USD
CY2020Q4	us-gaap	Junior Subordinated Debenture Owed To Unconsolidated Subsidiary Trust JuniorSubordinatedDebentureOwedToUnconsolidatedSubsidiaryTrust	5155000	USD
CY2021Q3	cvcy	Accrued Interest Payable And Other Liabilities AccruedInterestPayableAndOtherLiabilities	38582000	USD
CY2020Q4	cvcy	Accrued Interest Payable And Other Liabilities AccruedInterestPayableAndOtherLiabilities	31210000	USD
CY2021Q3	us-gaap	Liabilities Liabilities	2101829000	USD
CY2020Q4	us-gaap	Liabilities Liabilities	1759075000	USD
CY2021Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2020Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2021Q3	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2020Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2021Q3	us-gaap	Common Stock Value CommonStockValue	68265000	USD
CY2020Q4	us-gaap	Common Stock Value CommonStockValue	79416000	USD
CY2021Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	167993000	USD
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	150749000	USD
CY2021Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	10290000	USD
CY2020Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	14856000	USD
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	246548000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	245021000	USD
CY2021Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2348377000	USD
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2004096000	USD
CY2021Q3	us-gaap	Interest And Fee Income Loans And Leases InterestAndFeeIncomeLoansAndLeases	13208000	USD
CY2020Q3	us-gaap	Interest And Fee Income Loans And Leases InterestAndFeeIncomeLoansAndLeases	13190000	USD
	us-gaap	Interest And Fee Income Loans And Leases InterestAndFeeIncomeLoansAndLeases	40529000	USD
	us-gaap	Interest And Fee Income Loans And Leases InterestAndFeeIncomeLoansAndLeases	38688000	USD
CY2021Q3	us-gaap	Interest Income Deposits With Financial Institutions InterestIncomeDepositsWithFinancialInstitutions	28000	USD
CY2020Q3	us-gaap	Interest Income Deposits With Financial Institutions InterestIncomeDepositsWithFinancialInstitutions	26000	USD
	us-gaap	Interest Income Deposits With Financial Institutions InterestIncomeDepositsWithFinancialInstitutions	89000	USD
	us-gaap	Interest Income Deposits With Financial Institutions InterestIncomeDepositsWithFinancialInstitutions	222000	USD
CY2021Q3	us-gaap	Interest Income Securities Taxable InterestIncomeSecuritiesTaxable	3844000	USD
CY2020Q3	us-gaap	Interest Income Securities Taxable InterestIncomeSecuritiesTaxable	2771000	USD
	us-gaap	Interest Income Securities Taxable InterestIncomeSecuritiesTaxable	9938000	USD
	us-gaap	Interest Income Securities Taxable InterestIncomeSecuritiesTaxable	8996000	USD
CY2021Q3	us-gaap	Interest Income Securities Tax Exempt InterestIncomeSecuritiesTaxExempt	1417000	USD
CY2020Q3	us-gaap	Interest Income Securities Tax Exempt InterestIncomeSecuritiesTaxExempt	444000	USD
	us-gaap	Interest Income Securities Tax Exempt InterestIncomeSecuritiesTaxExempt	4143000	USD
	us-gaap	Interest Income Securities Tax Exempt InterestIncomeSecuritiesTaxExempt	1015000	USD
CY2021Q3	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	18497000	USD
CY2020Q3	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	16431000	USD
	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	54699000	USD
	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	48921000	USD
CY2021Q3	us-gaap	Interest Expense Domestic Deposits InterestExpenseDomesticDeposits	263000	USD
CY2020Q3	us-gaap	Interest Expense Domestic Deposits InterestExpenseDomesticDeposits	363000	USD
	us-gaap	Interest Expense Domestic Deposits InterestExpenseDomesticDeposits	783000	USD
	us-gaap	Interest Expense Domestic Deposits InterestExpenseDomesticDeposits	1169000	USD
CY2021Q3	us-gaap	Interest Expense Junior Subordinated Debentures InterestExpenseJuniorSubordinatedDebentures	24000	USD
CY2020Q3	us-gaap	Interest Expense Junior Subordinated Debentures InterestExpenseJuniorSubordinatedDebentures	25000	USD
	us-gaap	Interest Expense Junior Subordinated Debentures InterestExpenseJuniorSubordinatedDebentures	70000	USD
	us-gaap	Interest Expense Junior Subordinated Debentures InterestExpenseJuniorSubordinatedDebentures	106000	USD
CY2021Q3	us-gaap	Interest Expense InterestExpense	287000	USD
CY2020Q3	us-gaap	Interest Expense InterestExpense	388000	USD
	us-gaap	Interest Expense InterestExpense	853000	USD
	us-gaap	Interest Expense InterestExpense	1275000	USD
CY2021Q3	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	18210000	USD
CY2020Q3	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	16043000	USD
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	53846000	USD
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	47646000	USD
CY2021Q3	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	-500000	USD
CY2020Q3	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	600000	USD
	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	-3800000	USD
	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	4975000	USD
CY2021Q3	us-gaap	Interest Income Expense After Provision For Loan Loss InterestIncomeExpenseAfterProvisionForLoanLoss	18710000	USD
CY2020Q3	us-gaap	Interest Income Expense After Provision For Loan Loss InterestIncomeExpenseAfterProvisionForLoanLoss	15443000	USD
	us-gaap	Interest Income Expense After Provision For Loan Loss InterestIncomeExpenseAfterProvisionForLoanLoss	57646000	USD
	us-gaap	Interest Income Expense After Provision For Loan Loss InterestIncomeExpenseAfterProvisionForLoanLoss	42671000	USD
CY2021Q3	cvcy	Service Charges ServiceCharges	487000	USD
CY2020Q3	cvcy	Service Charges ServiceCharges	463000	USD
	cvcy	Service Charges ServiceCharges	1386000	USD
	cvcy	Service Charges ServiceCharges	1556000	USD
CY2021Q3	us-gaap	Bank Owned Life Insurance Income BankOwnedLifeInsuranceIncome	247000	USD
CY2020Q3	us-gaap	Bank Owned Life Insurance Income BankOwnedLifeInsuranceIncome	178000	USD
	us-gaap	Bank Owned Life Insurance Income BankOwnedLifeInsuranceIncome	596000	USD
	us-gaap	Bank Owned Life Insurance Income BankOwnedLifeInsuranceIncome	536000	USD
CY2021Q3	cvcy	Interchange Fees InterchangeFees	472000	USD
CY2020Q3	cvcy	Interchange Fees InterchangeFees	355000	USD
	cvcy	Interchange Fees InterchangeFees	1313000	USD
	cvcy	Interchange Fees InterchangeFees	995000	USD
CY2021Q3	us-gaap	Debt And Equity Securities Gain Loss DebtAndEquitySecuritiesGainLoss	117000	USD
CY2020Q3	us-gaap	Debt And Equity Securities Gain Loss DebtAndEquitySecuritiesGainLoss	57000	USD
	us-gaap	Debt And Equity Securities Gain Loss DebtAndEquitySecuritiesGainLoss	38000	USD
	us-gaap	Debt And Equity Securities Gain Loss DebtAndEquitySecuritiesGainLoss	4197000	USD
CY2021Q3	cvcy	Dividends Federal Home Loan Bank Stocks DividendsFederalHomeLoanBankStocks	84000	USD
CY2020Q3	cvcy	Dividends Federal Home Loan Bank Stocks DividendsFederalHomeLoanBankStocks	71000	USD
	cvcy	Dividends Federal Home Loan Bank Stocks DividendsFederalHomeLoanBankStocks	237000	USD
	cvcy	Dividends Federal Home Loan Bank Stocks DividendsFederalHomeLoanBankStocks	253000	USD
CY2021Q3	cvcy	Loan Placement Fees LoanPlacementFees	467000	USD
CY2020Q3	cvcy	Loan Placement Fees LoanPlacementFees	685000	USD
	cvcy	Loan Placement Fees LoanPlacementFees	1634000	USD
	cvcy	Loan Placement Fees LoanPlacementFees	1545000	USD
CY2021Q3	us-gaap	Noninterest Income Other Operating Income NoninterestIncomeOtherOperatingIncome	274000	USD
CY2020Q3	us-gaap	Noninterest Income Other Operating Income NoninterestIncomeOtherOperatingIncome	262000	USD
	us-gaap	Noninterest Income Other Operating Income NoninterestIncomeOtherOperatingIncome	1020000	USD
	us-gaap	Noninterest Income Other Operating Income NoninterestIncomeOtherOperatingIncome	1577000	USD
CY2021Q3	us-gaap	Noninterest Income NoninterestIncome	2148000	USD
CY2020Q3	us-gaap	Noninterest Income NoninterestIncome	2071000	USD
	us-gaap	Noninterest Income NoninterestIncome	6224000	USD
	us-gaap	Noninterest Income NoninterestIncome	10659000	USD
CY2021Q3	us-gaap	Labor And Related Expense LaborAndRelatedExpense	7091000	USD
CY2020Q3	us-gaap	Labor And Related Expense LaborAndRelatedExpense	6729000	USD
	us-gaap	Labor And Related Expense LaborAndRelatedExpense	21008000	USD
	us-gaap	Labor And Related Expense LaborAndRelatedExpense	21053000	USD
CY2021Q3	us-gaap	Occupancy Net OccupancyNet	1224000	USD
CY2020Q3	us-gaap	Occupancy Net OccupancyNet	1196000	USD
	us-gaap	Occupancy Net OccupancyNet	3538000	USD
	us-gaap	Occupancy Net OccupancyNet	3479000	USD
CY2021Q3	us-gaap	Professional Fees ProfessionalFees	507000	USD
CY2020Q3	us-gaap	Professional Fees ProfessionalFees	715000	USD
	us-gaap	Professional Fees ProfessionalFees	1338000	USD
	us-gaap	Professional Fees ProfessionalFees	1695000	USD
CY2021Q3	us-gaap	Information Technology And Data Processing InformationTechnologyAndDataProcessing	599000	USD
CY2020Q3	us-gaap	Information Technology And Data Processing InformationTechnologyAndDataProcessing	594000	USD
	us-gaap	Information Technology And Data Processing InformationTechnologyAndDataProcessing	1841000	USD
	us-gaap	Information Technology And Data Processing InformationTechnologyAndDataProcessing	1484000	USD
CY2021Q3	cvcy	Regulatory Assessments RegulatoryAssessments	219000	USD
CY2020Q3	cvcy	Regulatory Assessments RegulatoryAssessments	147000	USD
	cvcy	Regulatory Assessments RegulatoryAssessments	552000	USD
	cvcy	Regulatory Assessments RegulatoryAssessments	340000	USD
CY2021Q3	cvcy	At Mand Debit Card Expenses ATMandDebitCardExpenses	199000	USD
CY2020Q3	cvcy	At Mand Debit Card Expenses ATMandDebitCardExpenses	144000	USD
	cvcy	At Mand Debit Card Expenses ATMandDebitCardExpenses	615000	USD
	cvcy	At Mand Debit Card Expenses ATMandDebitCardExpenses	625000	USD
CY2021Q3	cvcy	Information Technology InformationTechnology	891000	USD
CY2020Q3	cvcy	Information Technology InformationTechnology	594000	USD
	cvcy	Information Technology InformationTechnology	2061000	USD
	cvcy	Information Technology InformationTechnology	1804000	USD
CY2021Q3	cvcy	Directors Expenses DirectorsExpenses	152000	USD
CY2020Q3	cvcy	Directors Expenses DirectorsExpenses	140000	USD
	cvcy	Directors Expenses DirectorsExpenses	306000	USD
	cvcy	Directors Expenses DirectorsExpenses	468000	USD
CY2021Q3	us-gaap	Advertising Expense AdvertisingExpense	129000	USD
CY2020Q3	us-gaap	Advertising Expense AdvertisingExpense	167000	USD
	us-gaap	Advertising Expense AdvertisingExpense	386000	USD
	us-gaap	Advertising Expense AdvertisingExpense	507000	USD
CY2021Q3	cvcy	Internet Banking Expense InternetBankingExpense	54000	USD
CY2020Q3	cvcy	Internet Banking Expense InternetBankingExpense	167000	USD
	cvcy	Internet Banking Expense InternetBankingExpense	262000	USD
	cvcy	Internet Banking Expense InternetBankingExpense	545000	USD
CY2021Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	174000	USD
CY2020Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	174000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	521000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	521000	USD
CY2021Q3	us-gaap	Other Noninterest Expense OtherNoninterestExpense	823000	USD
CY2020Q3	us-gaap	Other Noninterest Expense OtherNoninterestExpense	961000	USD
	us-gaap	Other Noninterest Expense OtherNoninterestExpense	2652000	USD
	us-gaap	Other Noninterest Expense OtherNoninterestExpense	2784000	USD
CY2021Q3	us-gaap	Noninterest Expense NoninterestExpense	12062000	USD
CY2020Q3	us-gaap	Noninterest Expense NoninterestExpense	11728000	USD
	us-gaap	Noninterest Expense NoninterestExpense	35080000	USD
	us-gaap	Noninterest Expense NoninterestExpense	35305000	USD
CY2021Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	8796000	USD
CY2020Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	12471070	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	12332248	shares
CY2020Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	5786000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	28790000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	18025000	USD
CY2021Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2275000	USD
CY2020Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1442000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	7227000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	4757000	USD
CY2021Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	6521000	USD
CY2020Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	4344000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	21563000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	13268000	USD
CY2021Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.54
CY2020Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.35
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.75
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.06
CY2021Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	12007689	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	12551480	shares
CY2021Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.54
CY2020Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.35
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.74
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.05
CY2021Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	12044896	shares
CY2020Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	12496174	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	12378591	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	12596172	shares
CY2021Q3	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.12
CY2020Q3	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.11
	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.35
	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.33
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	6521000	USD
CY2020Q3	us-gaap	Net Income Loss NetIncomeLoss	4344000	USD
	us-gaap	Net Income Loss NetIncomeLoss	21563000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	13268000	USD
CY2021Q3	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	-3552000	USD
CY2020Q3	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	5798000	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	-6444000	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	16477000	USD
CY2021Q3	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax	117000	USD
CY2020Q3	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax	57000	USD
	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax	38000	USD
	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax	4197000	USD
CY2021Q3	us-gaap	Other Comprehensive Income Loss Before Tax OtherComprehensiveIncomeLossBeforeTax	-3669000	USD
CY2020Q3	us-gaap	Other Comprehensive Income Loss Before Tax OtherComprehensiveIncomeLossBeforeTax	5741000	USD
	us-gaap	Other Comprehensive Income Loss Before Tax OtherComprehensiveIncomeLossBeforeTax	-6482000	USD
	us-gaap	Other Comprehensive Income Loss Before Tax OtherComprehensiveIncomeLossBeforeTax	12280000	USD
CY2021Q3	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	-1085000	USD
CY2020Q3	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	1698000	USD
	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	-1916000	USD
	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	3631000	USD
CY2021Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-2584000	USD
CY2020Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	4043000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-4566000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	8649000	USD
CY2021Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	3937000	USD
CY2020Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	8387000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	16997000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	21917000	USD
CY2020Q2	us-gaap	Stockholders Equity StockholdersEquity	228558000	USD
CY2020Q3	us-gaap	Net Income Loss NetIncomeLoss	4344000	USD
CY2020Q3	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	4043000	USD
CY2020Q3	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	0	USD
CY2020Q3	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	47000	USD
CY2020Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	113000	USD
CY2020Q3	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	1375000	USD
CY2020Q3	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	50000	USD
CY2020Q3	us-gaap	Stockholders Equity StockholdersEquity	235780000	USD
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	251049000	USD
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	6521000	USD
CY2021Q3	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-2584000	USD
CY2021Q3	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	48000	USD
CY2021Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	100000	USD
CY2021Q3	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	1438000	USD
CY2021Q3	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	10000	USD
CY2021Q3	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	7158000	USD
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	246548000	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	228128000	USD
	us-gaap	Net Income Loss NetIncomeLoss	13268000	USD
	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	8649000	USD
	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	162000	USD
	us-gaap	Stock Issued During Period Value Employee Stock Ownership Plan StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan	141000	USD
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	362000	USD
	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	4155000	USD
	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	11052000	USD
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	277000	USD
CY2020Q3	us-gaap	Stockholders Equity StockholdersEquity	235780000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	245021000	USD
	us-gaap	Net Income Loss NetIncomeLoss	21563000	USD
	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-4566000	USD
	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	159000	USD
	us-gaap	Stock Issued During Period Value Employee Stock Ownership Plan StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan	158000	USD
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	310000	USD
	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	4319000	USD
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	222000	USD
	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	12000000	USD
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	246548000	USD
	us-gaap	Net Income Loss NetIncomeLoss	21563000	USD
	us-gaap	Net Income Loss NetIncomeLoss	13268000	USD
	cvcy	Decrease Deferred Loan Costs DecreaseDeferredLoanCosts	-2203000	USD
	cvcy	Decrease Deferred Loan Costs DecreaseDeferredLoanCosts	5304000	USD
	us-gaap	Depreciation Nonproduction DepreciationNonproduction	688000	USD
	us-gaap	Depreciation Nonproduction DepreciationNonproduction	668000	USD
	cvcy	Accretion Amortizationof Discountsand Premiums AccretionAmortizationofDiscountsandPremiums	1050000	USD
	cvcy	Accretion Amortizationof Discountsand Premiums AccretionAmortizationofDiscountsandPremiums	994000	USD
	us-gaap	Adjustment For Amortization AdjustmentForAmortization	5752000	USD
	us-gaap	Adjustment For Amortization AdjustmentForAmortization	3328000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	310000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	362000	USD
	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	-3800000	USD
	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	4975000	USD
	us-gaap	Availableforsale Securities Gross Realized Gain Loss Excluding Other Than Temporary Impairments AvailableforsaleSecuritiesGrossRealizedGainLossExcludingOtherThanTemporaryImpairments	38000	USD
	us-gaap	Availableforsale Securities Gross Realized Gain Loss Excluding Other Than Temporary Impairments AvailableforsaleSecuritiesGrossRealizedGainLossExcludingOtherThanTemporaryImpairments	4197000	USD
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	8000	USD
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	6000	USD
	us-gaap	Increase Decrease In Trading Securities IncreaseDecreaseInTradingSecurities	-148000	USD
	us-gaap	Increase Decrease In Trading Securities IncreaseDecreaseInTradingSecurities	183000	USD
	us-gaap	Life Insurance Corporate Or Bank Owned Change In Value LifeInsuranceCorporateOrBankOwnedChangeInValue	596000	USD
	us-gaap	Life Insurance Corporate Or Bank Owned Change In Value LifeInsuranceCorporateOrBankOwnedChangeInValue	376000	USD
	cvcy	Gain Loss On Bank Owned Life Insurance GainLossOnBankOwnedLifeInsurance	0	USD
	cvcy	Gain Loss On Bank Owned Life Insurance GainLossOnBankOwnedLifeInsurance	462000	USD
	cvcy	Increase Decrease In Accrued Interest Receivable And Other Operating Assets Net IncreaseDecreaseInAccruedInterestReceivableAndOtherOperatingAssetsNet	1878000	USD
	cvcy	Increase Decrease In Accrued Interest Receivable And Other Operating Assets Net IncreaseDecreaseInAccruedInterestReceivableAndOtherOperatingAssetsNet	1394000	USD
	cvcy	Increase Decrease In Interest Payable And Other Operating Liabilities Net IncreaseDecreaseInInterestPayableAndOtherOperatingLiabilitiesNet	7529000	USD
	cvcy	Increase Decrease In Interest Payable And Other Operating Liabilities Net IncreaseDecreaseInInterestPayableAndOtherOperatingLiabilitiesNet	-1636000	USD
	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	-1256000	USD
	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	1227000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	32079000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	6822000	USD
	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	410308000	USD
	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	319707000	USD
	us-gaap	Proceeds From Sale Of Available For Sale Securities ProceedsFromSaleOfAvailableForSaleSecurities	10760000	USD
	us-gaap	Proceeds From Sale Of Available For Sale Securities ProceedsFromSaleOfAvailableForSaleSecurities	147811000	USD
	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	38727000	USD
	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	25536000	USD
	us-gaap	Payments For Proceeds From Loans And Leases PaymentsForProceedsFromLoansAndLeases	-17593000	USD
	us-gaap	Payments For Proceeds From Loans And Leases PaymentsForProceedsFromLoansAndLeases	160653000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	889000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	307000	USD
	us-gaap	Payments To Acquire Life Insurance Policies PaymentsToAcquireLifeInsurancePolicies	10000000	USD
	us-gaap	Payments To Acquire Life Insurance Policies PaymentsToAcquireLifeInsurancePolicies	250000	USD
	us-gaap	Payments For Proceeds From Federal Home Loan Bank Stock PaymentsForProceedsFromFederalHomeLoanBankStock	0	USD
	us-gaap	Payments For Proceeds From Federal Home Loan Bank Stock PaymentsForProceedsFromFederalHomeLoanBankStock	-467000	USD
	us-gaap	Proceeds From Life Insurance Policies ProceedsFromLifeInsurancePolicies	0	USD
	us-gaap	Proceeds From Life Insurance Policies ProceedsFromLifeInsurancePolicies	1550000	USD
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	9000	USD
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	6000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-354108000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-305547000	USD
	cvcy	Net Increase Decrease In Demand Interest Bearing And Savings Deposits NetIncreaseDecreaseInDemandInterestBearingAndSavingsDeposits	335370000	USD
	cvcy	Net Increase Decrease In Demand Interest Bearing And Savings Deposits NetIncreaseDecreaseInDemandInterestBearingAndSavingsDeposits	353622000	USD
	us-gaap	Increase Decrease In Time Deposits IncreaseDecreaseInTimeDeposits	12000	USD
	us-gaap	Increase Decrease In Time Deposits IncreaseDecreaseInTimeDeposits	-5693000	USD
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	12000000	USD
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	11052000	USD
	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	159000	USD
	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	162000	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	222000	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	277000	USD
	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	4319000	USD
	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	4155000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	319444000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	333161000	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-2585000	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	34436000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	70278000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	52574000	USD
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	67693000	USD
CY2020Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	87010000	USD
	us-gaap	Interest Paid Net InterestPaidNet	866000	USD
	us-gaap	Interest Paid Net InterestPaidNet	1354000	USD
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	6755000	USD
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	5120000	USD
	us-gaap	Operating Lease Payments OperatingLeasePayments	1688000	USD
	us-gaap	Operating Lease Payments OperatingLeasePayments	1678000	USD
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	No customer accounts for more than 10 percent of revenues for the Company or the Bank.
	cvcy	Threshold Amount Of Value Decline In Available For Sale Securities To Be Considered Other Than Temporary Impairment ThresholdAmountOfValueDeclineInAvailableForSaleSecuritiesToBeConsideredOtherThanTemporaryImpairment	75000	USD
CY2021Q3	us-gaap	Pledged Assets Separately Reported Securities Pledged As Collateral At Fair Value PledgedAssetsSeparatelyReportedSecuritiesPledgedAsCollateralAtFairValue	262024000	USD
CY2021Q3	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Gain Loss Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainLossBeforeTax	14609000	USD
CY2020Q4	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Gain Loss Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainLossBeforeTax	21091000	USD
CY2021Q3	cvcy	Accumulated Other Comprehensive Income Available For Sale Securities Adjustment Tax AccumulatedOtherComprehensiveIncomeAvailableForSaleSecuritiesAdjustmentTax	4319000000	USD
CY2020Q4	cvcy	Accumulated Other Comprehensive Income Available For Sale Securities Adjustment Tax AccumulatedOtherComprehensiveIncomeAvailableForSaleSecuritiesAdjustmentTax	6235000	USD
CY2021Q3	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	1045753000	USD
CY2021Q3	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	20781000	USD
CY2021Q3	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	6172000	USD
CY2021Q3	us-gaap	Available For Sale Securities AvailableForSaleSecurities	1060362000	USD
CY2020Q4	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	689001000	USD
CY2020Q4	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	23371000	USD
CY2020Q4	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	2280000	USD
CY2020Q4	us-gaap	Available For Sale Securities AvailableForSaleSecurities	710092000	USD
CY2021Q3	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	10170000	USD
CY2020Q3	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	25442000	USD
	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	10760000	USD
	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	147811000	USD
CY2021Q3	us-gaap	Available For Sale Securities Gross Realized Gains AvailableForSaleSecuritiesGrossRealizedGains	117000	USD
CY2020Q3	us-gaap	Available For Sale Securities Gross Realized Gains AvailableForSaleSecuritiesGrossRealizedGains	1035000	USD
	us-gaap	Available For Sale Securities Gross Realized Gains AvailableForSaleSecuritiesGrossRealizedGains	117000	USD
	us-gaap	Available For Sale Securities Gross Realized Gains AvailableForSaleSecuritiesGrossRealizedGains	5539000	USD
CY2021Q3	us-gaap	Available For Sale Securities Gross Realized Losses AvailableForSaleSecuritiesGrossRealizedLosses	0	USD
CY2020Q3	us-gaap	Available For Sale Securities Gross Realized Losses AvailableForSaleSecuritiesGrossRealizedLosses	978000	USD
	us-gaap	Available For Sale Securities Gross Realized Losses AvailableForSaleSecuritiesGrossRealizedLosses	79000	USD
	us-gaap	Available For Sale Securities Gross Realized Losses AvailableForSaleSecuritiesGrossRealizedLosses	1342000	USD
	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax	11000	USD
	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax	1241000	USD
CY2021Q3	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax	35000	USD
CY2020Q3	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax	17000	USD
CY2021Q3	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months	380802000	USD
CY2021Q3	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	5548000	USD
CY2021Q3	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger	54913000	USD
CY2021Q3	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	624000	USD
CY2021Q3	us-gaap	Debt Securities Available For Sale Unrealized Loss Position DebtSecuritiesAvailableForSaleUnrealizedLossPosition	435715000	USD
CY2021Q3	us-gaap	Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss	6172000	USD
CY2020Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months	105252000	USD
CY2020Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	1085000	USD
CY2020Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger	81237000	USD
CY2020Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	1195000	USD
CY2020Q4	us-gaap	Debt Securities Available For Sale Unrealized Loss Position DebtSecuritiesAvailableForSaleUnrealizedLossPosition	186489000	USD
CY2020Q4	us-gaap	Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss	2280000	USD
	cvcy	Threshold Period Of Value Decline In Available For Sale Securities To Be Considered Other Than Temporary Impairment ThresholdPeriodOfValueDeclineInAvailableForSaleSecuritiesToBeConsideredOtherThanTemporaryImpairment	P12M
	cvcy	Threshold Percentage Of Value Decline In Available For Sale Securities To Be Considered Other Than Temporary Impairment ThresholdPercentageOfValueDeclineInAvailableForSaleSecuritiesToBeConsideredOtherThanTemporaryImpairment	0.10
	us-gaap	Impairment Of Investments ImpairmentOfInvestments	0	USD
CY2021Q3	cvcy	Available For Sale Securities Number Of Securities Loss Position AvailableForSaleSecuritiesNumberOfSecuritiesLossPosition	8	Loans
CY2021Q3	us-gaap	Available For Sale Securities Debt Maturities Within One Year Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost	0	USD
CY2021Q3	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	0	USD
CY2021Q3	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost	3349000	USD
CY2021Q3	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	3659000	USD
CY2021Q3	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost	94640000	USD
CY2021Q3	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue	97424000	USD
CY2021Q3	us-gaap	Available For Sale Securities Debt Maturities After Ten Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost	406424000	USD
CY2021Q3	us-gaap	Available For Sale Securities Debt Maturities After Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue	416847000	USD
CY2021Q3	cvcy	Available For Sale Securities Debt Maturities With Single Maturity Date Amortized Cost Basis AvailableForSaleSecuritiesDebtMaturitiesWithSingleMaturityDateAmortizedCostBasis	504413000	USD
CY2021Q3	cvcy	Available For Sale Securities Debt Maturities With Single Maturity Date Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithSingleMaturityDateFairValue	517930000	USD
CY2021Q3	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	1045753000	USD
CY2021Q3	us-gaap	Available For Sale Securities AvailableForSaleSecurities	1060362000	USD
CY2021Q3	us-gaap	Unamortized Loan Commitment And Origination Fees And Unamortized Discounts Or Premiums UnamortizedLoanCommitmentAndOriginationFeesAndUnamortizedDiscountsOrPremiums	-409000	USD
CY2020Q4	us-gaap	Unamortized Loan Commitment And Origination Fees And Unamortized Discounts Or Premiums UnamortizedLoanCommitmentAndOriginationFeesAndUnamortizedDiscountsOrPremiums	-2612000	USD
CY2021Q3	us-gaap	Loans And Leases Receivable Gross Carrying Amount LoansAndLeasesReceivableGrossCarryingAmount	1083497000	USD
CY2021Q3	cvcy	Loans And Leases Receivable Percentage Of Gross Loans LoansAndLeasesReceivablePercentageOfGrossLoans	1.000
CY2020Q4	us-gaap	Loans And Leases Receivable Gross Carrying Amount LoansAndLeasesReceivableGrossCarryingAmount	1102347000	USD
CY2020Q4	cvcy	Loans And Leases Receivable Percentage Of Gross Loans LoansAndLeasesReceivablePercentageOfGrossLoans	1.000
CY2021Q3	us-gaap	Loans And Leases Receivable Allowance LoansAndLeasesReceivableAllowance	10061000	USD
CY2020Q4	us-gaap	Loans And Leases Receivable Allowance LoansAndLeasesReceivableAllowance	12915000	USD
CY2021Q3	us-gaap	Loans And Leases Receivable Net Reported Amount LoansAndLeasesReceivableNetReportedAmount	1073436000	USD
CY2020Q4	us-gaap	Loans And Leases Receivable Net Reported Amount LoansAndLeasesReceivableNetReportedAmount	1089432000	USD
CY2021Q3	cvcy	Loansand Leases Receivable Allowance Numberof Components LoansandLeasesReceivableAllowanceNumberofComponents	2	component
CY2021Q3	cvcy	Financing Receivable Allowance For Credit Losses Methodology Change Number Of Rolling Quarters Used In Analysis FinancingReceivableAllowanceForCreditLossesMethodologyChangeNumberOfRollingQuartersUsedInAnalysis	51	quarter
CY2021Q2	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	10439000	USD
CY2021Q3	us-gaap	Provision For Loan Lease And Other Losses ProvisionForLoanLeaseAndOtherLosses	500000	USD
CY2021Q3	us-gaap	Financing Receivable Allowance For Credit Losses Write Offs FinancingReceivableAllowanceForCreditLossesWriteOffs	34000	USD
CY2021Q3	us-gaap	Financing Receivable Allowance For Credit Losses Recovery FinancingReceivableAllowanceForCreditLossesRecovery	156000	USD
CY2021Q3	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	10061000	USD
CY2020Q2	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	13937000	USD
CY2020Q3	us-gaap	Provision For Loan Lease And Other Losses ProvisionForLoanLeaseAndOtherLosses	600000	USD
CY2020Q3	us-gaap	Financing Receivable Allowance For Credit Losses Write Offs FinancingReceivableAllowanceForCreditLossesWriteOffs	45000	USD
CY2020Q3	us-gaap	Financing Receivable Allowance For Credit Losses Recovery FinancingReceivableAllowanceForCreditLossesRecovery	165000	USD
CY2020Q3	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	14657000	USD
CY2020Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	12915000	USD
	us-gaap	Provision For Loan Lease And Other Losses ProvisionForLoanLeaseAndOtherLosses	3800000	USD
	us-gaap	Financing Receivable Allowance For Credit Losses Write Offs FinancingReceivableAllowanceForCreditLossesWriteOffs	261000	USD
	us-gaap	Financing Receivable Allowance For Credit Losses Recovery FinancingReceivableAllowanceForCreditLossesRecovery	1207000	USD
CY2021Q3	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	10061000	USD
CY2019Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	9130000	USD
	us-gaap	Provision For Loan Lease And Other Losses ProvisionForLoanLeaseAndOtherLosses	-4975000	USD
	us-gaap	Financing Receivable Allowance For Credit Losses Write Offs FinancingReceivableAllowanceForCreditLossesWriteOffs	169000	USD
	us-gaap	Financing Receivable Allowance For Credit Losses Recovery FinancingReceivableAllowanceForCreditLossesRecovery	721000	USD
CY2020Q3	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	14657000	USD
CY2021Q3	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	10061000	USD
CY2021Q3	us-gaap	Financing Receivable Allowance For Credit Losses Individually Evaluated For Impairment1 FinancingReceivableAllowanceForCreditLossesIndividuallyEvaluatedForImpairment1	931000	USD
CY2021Q3	us-gaap	Financing Receivable Allowance For Credit Losses Collectively Evaluated For Impairment FinancingReceivableAllowanceForCreditLossesCollectivelyEvaluatedForImpairment	9130000	USD
CY2020Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	12915000	USD
CY2020Q4	us-gaap	Financing Receivable Allowance For Credit Losses Individually Evaluated For Impairment1 FinancingReceivableAllowanceForCreditLossesIndividuallyEvaluatedForImpairment1	631000	USD
CY2020Q4	us-gaap	Financing Receivable Allowance For Credit Losses Collectively Evaluated For Impairment FinancingReceivableAllowanceForCreditLossesCollectivelyEvaluatedForImpairment	12284000	USD
CY2021Q3	us-gaap	Notes Receivable Gross NotesReceivableGross	1083906000	USD
CY2021Q3	us-gaap	Financing Receivable Individually Evaluated For Impairment FinancingReceivableIndividuallyEvaluatedForImpairment	10060000	USD
CY2021Q3	us-gaap	Financing Receivable Collectively Evaluated For Impairment FinancingReceivableCollectivelyEvaluatedForImpairment	1073846000	USD
CY2020Q4	us-gaap	Notes Receivable Gross NotesReceivableGross	1104959000	USD
CY2020Q4	us-gaap	Financing Receivable Individually Evaluated For Impairment FinancingReceivableIndividuallyEvaluatedForImpairment	11186000	USD
CY2020Q4	us-gaap	Financing Receivable Collectively Evaluated For Impairment FinancingReceivableCollectivelyEvaluatedForImpairment	1093773000	USD
CY2021Q3	us-gaap	Notes Receivable Gross NotesReceivableGross	1083906000	USD
CY2020Q4	us-gaap	Notes Receivable Gross NotesReceivableGross	1104959000	USD
CY2021Q3	us-gaap	Notes Receivable Gross NotesReceivableGross	1083906000	USD
CY2021Q3	us-gaap	Financing Receivable Recorded Investment90 Days Past Due And Still Accruing FinancingReceivableRecordedInvestment90DaysPastDueAndStillAccruing	0	USD
CY2021Q3	us-gaap	Financing Receivable Recorded Investment Nonaccrual Status FinancingReceivableRecordedInvestmentNonaccrualStatus	1597000	USD
CY2020Q4	us-gaap	Notes Receivable Gross NotesReceivableGross	1104959000	USD
CY2020Q4	us-gaap	Financing Receivable Recorded Investment90 Days Past Due And Still Accruing FinancingReceivableRecordedInvestment90DaysPastDueAndStillAccruing	0	USD
CY2020Q4	us-gaap	Financing Receivable Recorded Investment Nonaccrual Status FinancingReceivableRecordedInvestmentNonaccrualStatus	3278000	USD
CY2021Q3	us-gaap	Impaired Financing Receivable With No Related Allowance Recorded Investment ImpairedFinancingReceivableWithNoRelatedAllowanceRecordedInvestment	624000	USD
CY2021Q3	us-gaap	Impaired Financing Receivable With No Related Allowance Unpaid Principal Balance ImpairedFinancingReceivableWithNoRelatedAllowanceUnpaidPrincipalBalance	727000	USD
CY2021Q3	us-gaap	Impaired Financing Receivable With Related Allowance Recorded Investment ImpairedFinancingReceivableWithRelatedAllowanceRecordedInvestment	9436000	USD
CY2021Q3	us-gaap	Impaired Financing Receivable With Related Allowance Unpaid Principal Balance ImpairedFinancingReceivableWithRelatedAllowanceUnpaidPrincipalBalance	9536000	USD
CY2021Q3	us-gaap	Impaired Financing Receivable Related Allowance ImpairedFinancingReceivableRelatedAllowance	931000	USD
CY2021Q3	us-gaap	Impaired Financing Receivable Recorded Investment ImpairedFinancingReceivableRecordedInvestment	10060000	USD
CY2021Q3	us-gaap	Impaired Financing Receivable Unpaid Principal Balance ImpairedFinancingReceivableUnpaidPrincipalBalance	10263000	USD
CY2021Q3	us-gaap	Impaired Financing Receivable Related Allowance ImpairedFinancingReceivableRelatedAllowance	931000	USD
CY2020Q4	us-gaap	Impaired Financing Receivable With No Related Allowance Recorded Investment ImpairedFinancingReceivableWithNoRelatedAllowanceRecordedInvestment	1114000	USD
CY2020Q4	us-gaap	Impaired Financing Receivable With No Related Allowance Unpaid Principal Balance ImpairedFinancingReceivableWithNoRelatedAllowanceUnpaidPrincipalBalance	1239000	USD
CY2020Q4	us-gaap	Impaired Financing Receivable With Related Allowance Recorded Investment ImpairedFinancingReceivableWithRelatedAllowanceRecordedInvestment	10072000	USD
CY2020Q4	us-gaap	Impaired Financing Receivable With Related Allowance Unpaid Principal Balance ImpairedFinancingReceivableWithRelatedAllowanceUnpaidPrincipalBalance	10132000	USD
CY2020Q4	us-gaap	Impaired Financing Receivable Related Allowance ImpairedFinancingReceivableRelatedAllowance	631000	USD
CY2020Q4	us-gaap	Impaired Financing Receivable Recorded Investment ImpairedFinancingReceivableRecordedInvestment	11186000	USD
CY2020Q4	us-gaap	Impaired Financing Receivable Unpaid Principal Balance ImpairedFinancingReceivableUnpaidPrincipalBalance	11371000	USD
CY2020Q4	us-gaap	Impaired Financing Receivable Related Allowance ImpairedFinancingReceivableRelatedAllowance	631000	USD
CY2021Q3	us-gaap	Impaired Financing Receivable With No Related Allowance Average Recorded Investment ImpairedFinancingReceivableWithNoRelatedAllowanceAverageRecordedInvestment	861000	USD
CY2021Q3	us-gaap	Impaired Financing Receivable With No Related Allowance Interest Income Accrual Method ImpairedFinancingReceivableWithNoRelatedAllowanceInterestIncomeAccrualMethod	3000	USD
CY2020Q3	us-gaap	Impaired Financing Receivable With No Related Allowance Average Recorded Investment ImpairedFinancingReceivableWithNoRelatedAllowanceAverageRecordedInvestment	5536000	USD
CY2020Q3	us-gaap	Impaired Financing Receivable With No Related Allowance Interest Income Accrual Method ImpairedFinancingReceivableWithNoRelatedAllowanceInterestIncomeAccrualMethod	3000	USD
CY2021Q3	us-gaap	Impaired Financing Receivable With Related Allowance Average Recorded Investment ImpairedFinancingReceivableWithRelatedAllowanceAverageRecordedInvestment	7768000	USD
CY2021Q3	us-gaap	Impaired Financing Receivable With Related Allowance Interest Income Accrual Method ImpairedFinancingReceivableWithRelatedAllowanceInterestIncomeAccrualMethod	150000	USD
CY2020Q3	us-gaap	Impaired Financing Receivable With Related Allowance Average Recorded Investment ImpairedFinancingReceivableWithRelatedAllowanceAverageRecordedInvestment	8066000	USD
CY2020Q3	us-gaap	Impaired Financing Receivable With Related Allowance Interest Income Accrual Method ImpairedFinancingReceivableWithRelatedAllowanceInterestIncomeAccrualMethod	167000	USD
CY2021Q3	us-gaap	Impaired Financing Receivable Average Recorded Investment ImpairedFinancingReceivableAverageRecordedInvestment	8629000	USD
CY2021Q3	us-gaap	Impaired Financing Receivable Interest Income Accrual Method ImpairedFinancingReceivableInterestIncomeAccrualMethod	153000	USD
CY2020Q3	us-gaap	Impaired Financing Receivable Average Recorded Investment ImpairedFinancingReceivableAverageRecordedInvestment	13602000	USD
CY2020Q3	us-gaap	Impaired Financing Receivable Interest Income Accrual Method ImpairedFinancingReceivableInterestIncomeAccrualMethod	170000	USD
	us-gaap	Impaired Financing Receivable With No Related Allowance Average Recorded Investment ImpairedFinancingReceivableWithNoRelatedAllowanceAverageRecordedInvestment	918000	USD
	us-gaap	Impaired Financing Receivable With No Related Allowance Interest Income Accrual Method ImpairedFinancingReceivableWithNoRelatedAllowanceInterestIncomeAccrualMethod	9000	USD
	us-gaap	Impaired Financing Receivable With No Related Allowance Average Recorded Investment ImpairedFinancingReceivableWithNoRelatedAllowanceAverageRecordedInvestment	3486000	USD
	us-gaap	Impaired Financing Receivable With No Related Allowance Interest Income Accrual Method ImpairedFinancingReceivableWithNoRelatedAllowanceInterestIncomeAccrualMethod	9000	USD
	us-gaap	Impaired Financing Receivable With Related Allowance Average Recorded Investment ImpairedFinancingReceivableWithRelatedAllowanceAverageRecordedInvestment	9104000	USD
	us-gaap	Impaired Financing Receivable With Related Allowance Interest Income Accrual Method ImpairedFinancingReceivableWithRelatedAllowanceInterestIncomeAccrualMethod	346000	USD
	us-gaap	Impaired Financing Receivable With Related Allowance Average Recorded Investment ImpairedFinancingReceivableWithRelatedAllowanceAverageRecordedInvestment	7818000	USD
	us-gaap	Impaired Financing Receivable With Related Allowance Interest Income Accrual Method ImpairedFinancingReceivableWithRelatedAllowanceInterestIncomeAccrualMethod	569000	USD
	us-gaap	Impaired Financing Receivable Average Recorded Investment ImpairedFinancingReceivableAverageRecordedInvestment	10022000	USD
	us-gaap	Impaired Financing Receivable Interest Income Accrual Method ImpairedFinancingReceivableInterestIncomeAccrualMethod	355000	USD
	us-gaap	Impaired Financing Receivable Average Recorded Investment ImpairedFinancingReceivableAverageRecordedInvestment	11304000	USD
	us-gaap	Impaired Financing Receivable Interest Income Accrual Method ImpairedFinancingReceivableInterestIncomeAccrualMethod	578000	USD
	us-gaap	Loans And Leases Receivable Impaired Interest Lost On Nonaccrual Loans LoansAndLeasesReceivableImpairedInterestLostOnNonaccrualLoans	101000	USD
CY2020	us-gaap	Loans And Leases Receivable Impaired Interest Lost On Nonaccrual Loans LoansAndLeasesReceivableImpairedInterestLostOnNonaccrualLoans	135000	USD
CY2021Q3	us-gaap	Loans And Leases Receivable Impaired Interest Lost On Nonaccrual Loans LoansAndLeasesReceivableImpairedInterestLostOnNonaccrualLoans	30000	USD
CY2020Q4	us-gaap	Loans And Leases Receivable Impaired Interest Lost On Nonaccrual Loans LoansAndLeasesReceivableImpairedInterestLostOnNonaccrualLoans	82000	USD
CY2021Q3	us-gaap	Financing Receivable Modifications Recorded Investment FinancingReceivableModificationsRecordedInvestment	8463000	USD
CY2020Q4	us-gaap	Financing Receivable Modifications Recorded Investment FinancingReceivableModificationsRecordedInvestment	7908000	USD
CY2021Q3	cvcy	Financing Receivable Modifications Related Allowance FinancingReceivableModificationsRelatedAllowance	678000	USD
CY2020Q4	cvcy	Financing Receivable Modifications Related Allowance FinancingReceivableModificationsRelatedAllowance	20000	USD
CY2021Q3	us-gaap	Financing Receivable Modifications Number Of Contracts2 FinancingReceivableModificationsNumberOfContracts2	2	Loans
	cvcy	Financing Receivable Modifications Subsequent Defaults During Period Number Of Contracts FinancingReceivableModificationsSubsequentDefaultsDuringPeriodNumberOfContracts	0	contract
	cvcy	Financing Receivable Modifications Subsequent Defaults During Period Number Of Contracts FinancingReceivableModificationsSubsequentDefaultsDuringPeriodNumberOfContracts	0	contract
CY2021Q3	us-gaap	Goodwill Goodwill	53777000	USD
CY2020Q4	us-gaap	Federal Funds Purchased FederalFundsPurchased	0	USD
CY2021Q3	us-gaap	Federal Funds Purchased FederalFundsPurchased	0	USD
CY2021Q3	us-gaap	Other Commitment OtherCommitment	2975000	USD
CY2021Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	6521000	USD
CY2020Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	4344000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	21563000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	13268000	USD
CY2021Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	12007689	shares
CY2020Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	12471070	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	12332248	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	12551480	shares
CY2021Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.54
CY2020Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.35
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.75
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.06
CY2021Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	6521000	USD
CY2020Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	4344000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	21563000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	13268000	USD
CY2021Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	12007689	shares
CY2020Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	12471070	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	12332248	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	12551480	shares
CY2021Q3	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	37207	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
CY2020Q3	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	25104	shares
	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	46343	shares
	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	44692	shares
CY2021Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	12044896	shares
CY2020Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	12496174	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	12378591	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	12596172	shares
CY2021Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.54
CY2020Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.35
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.74
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.05
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	0	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	0	shares
CY2021Q3	cvcy	Sharebased Compensation Arrangementby Sharebased Payment Award Numberof Plans SharebasedCompensationArrangementbySharebasedPaymentAwardNumberofPlans	4	plan
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	310000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	362000	USD
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	77070	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	10.06
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	21285	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	10.44
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	55785	shares
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	9.92
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P0Y9M25D
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	650000	USD
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber	55785	shares
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice	9.92
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1	P0Y9M25D
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue	650000	USD
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	19000	USD
CY2020Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	51000	USD
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	225000	USD
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	432000	USD
CY2021Q3	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	0	USD
CY2021Q3	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	10000	USD
CY2020Q3	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	50000	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	222000	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	277000	USD
CY2021Q3	us-gaap	Employee Service Share Based Compensation Tax Benefit From Exercise Of Stock Options EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions	4000	USD
CY2020Q3	us-gaap	Employee Service Share Based Compensation Tax Benefit From Exercise Of Stock Options EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions	6000	USD
	us-gaap	Employee Service Share Based Compensation Tax Benefit From Exercise Of Stock Options EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions	50000	USD
	us-gaap	Employee Service Share Based Compensation Tax Benefit From Exercise Of Stock Options EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions	78000	USD
CY2021Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.54
CY2020Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.35
CY2021Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.54
CY2020Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.35
CY2021Q3	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	-500000	USD
CY2020Q3	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	600000	USD
CY2021Q3	us-gaap	Interest And Fee Income Loans And Leases InterestAndFeeIncomeLoansAndLeases	13208000	USD
CY2020Q3	us-gaap	Interest And Fee Income Loans And Leases InterestAndFeeIncomeLoansAndLeases	13190000	USD
CY2021Q3	us-gaap	Interest Expense Domestic Deposits InterestExpenseDomesticDeposits	263000	USD
CY2020Q3	us-gaap	Interest Expense Domestic Deposits InterestExpenseDomesticDeposits	363000	USD
CY2021Q3	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	-500000	USD
CY2020Q3	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	600000	USD
CY2021Q3	cvcy	Service Charges ServiceCharges	487000	USD
CY2020Q3	cvcy	Service Charges ServiceCharges	463000	USD
CY2021Q3	us-gaap	Noninterest Income Other Operating Income NoninterestIncomeOtherOperatingIncome	274000	USD
CY2020Q3	us-gaap	Noninterest Income Other Operating Income NoninterestIncomeOtherOperatingIncome	262000	USD
CY2021Q3	us-gaap	Labor And Related Expense LaborAndRelatedExpense	7091000	USD
CY2020Q3	us-gaap	Labor And Related Expense LaborAndRelatedExpense	6729000	USD
CY2021Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2275000	USD
CY2020Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1442000	USD

Files In Submission

Name	View Source	Status
0001127371-21-000141-index-headers.html	Edgar Link	pending
0001127371-21-000141-index.html	Edgar Link	pending
0001127371-21-000141.txt	Edgar Link	pending
0001127371-21-000141-xbrl.zip	Edgar Link	pending
cvcy-20210930.htm	Edgar Link	pending
cvcy-20210930.xsd	Edgar Link	pending
cvcy-20210930_cal.xml	Edgar Link	unprocessable
cvcy-20210930_def.xml	Edgar Link	unprocessable
cvcy-20210930_htm.xml	Edgar Link	completed
cvcy-20210930_lab.xml	Edgar Link	unprocessable
cvcy-20210930_pre.xml	Edgar Link	unprocessable
exhibit3112021q3-ng.htm	Edgar Link	pending
exhibit3122021q3-ng.htm	Edgar Link	pending
exhibit3212021q3-ng.htm	Edgar Link	pending
exhibit3222021q3-ng.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CWBC
Community West Bancshares Stock $cwbc

2021 Q3 Form 10-Q Financial Statement

#000112737121000141 Filed on November 03, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CWBC Community West Bancshares Stock $cwbc

2021 Q3 Form 10-Q Financial Statement

#000112737121000141 Filed on November 03, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CWBC
Community West Bancshares Stock $cwbc